SCHEDULE 13D/A: DCM Funds Increase Stake in QuantaSing Group to 27.8% Following Share Repurchases and Open Market Acquisitions
Ownership Disclosure (Schedule 13D Amendment)
DCM Ventures China Fund and its affiliates have increased their beneficial ownership in QuantaSing Group Ltd. to 27.8% of Class A Ordinary Shares, driven by the company's share repurchases and additional open market acquisitions.
Summary
- DCM Ventures China Fund (DCM VIII), L.P. and its affiliates (collectively, the "Reporting Persons") have filed an Amendment No. 1 to their Schedule 13D, updating their beneficial ownership in QuantaSing Group Ltd.
- The aggregate beneficial ownership of the Reporting Persons has increased to 28,870,389 Class A ordinary shares, representing 27.8% of the outstanding shares as of June 30, 2024.
- This increase in percentage ownership (over 1% since the original filing on November 17, 2023) is attributed to the Issuer's ongoing share repurchases and additional open market acquisitions by the Reporting Persons.
- The Reporting Persons' investment in QuantaSing Group Ltd. is for general investment purposes, and they reserve the right to adjust their holdings based on ongoing evaluations of the company's financial condition and market factors.
Sentiment
Score: 7
Explanation: The document indicates a significant institutional investor (DCM) has increased its stake in QuantaSing Group Ltd., partly due to the company's share repurchases and partly due to additional open market purchases by the investor. This suggests a positive view from a major shareholder and potentially a commitment to the company's long-term prospects.
Positives
- A significant institutional investor, DCM, has increased its beneficial ownership in QuantaSing Group Ltd. to 27.8%, indicating continued confidence.
- The increase in DCM's percentage ownership is partly due to QuantaSing Group Ltd.'s own share repurchase program, which can be a positive signal for shareholder value.
- DCM funds made additional open market purchases of QuantaSing ADSs in March 2024, demonstrating active investment.
Risks
- The Reporting Persons reserve the right to increase or decrease their holdings, including sales, which could impact the Company's share price.
- The value of the investment is subject to various factors including the Company's business and financial condition, general economic and industry conditions, and securities markets.
Future Outlook
The Reporting Persons intend to continuously evaluate QuantaSing Group Ltd.'s financial condition, prospects, and their investment based on various factors, including market conditions and other investment opportunities. They explicitly reserve the right to change their intentions and to increase or decrease their holdings at any time.
Industry Context
This filing is an ownership disclosure and does not provide specific industry context or trends. It primarily focuses on the investment activities of DCM funds in QuantaSing Group Ltd.
Related Party Transactions
- DCM funds (Main Fund VIII, Side Fund VIII, Affiliates Fund VIII) are significant investors in QuantaSing Group Ltd.
- Frank Hurst Lin, a director of DCM VIII UGP (the ultimate general partner of the DCM funds), is also a director of QuantaSing Group Ltd., establishing a related party relationship.
- The Amended and Restated Shareholders' Agreement and indemnification agreements are arrangements between the Company and these related parties.
Stakeholder Impact
- Shareholders: Increased confidence due to a major investor increasing its stake and the company's share repurchase activity. Potential for future share price volatility if DCM significantly alters its holdings.
- Management: Continued oversight and potential influence from a significant institutional investor.
Next Steps
- Reporting Persons will continue to evaluate QuantaSing Group Ltd.'s financial condition and prospects.
- Reporting Persons may increase or decrease their holdings in the Company in the future.
Key Dates
| Date | Description |
|---|---|
| April 23, 2018 | Main Fund VIII, Side Fund VIII, and Affiliates Fund VIII entered into Share Subscription Agreements to acquire Series B preferred shares. |
| June 7, 2018 | Main Fund VIII, Side Fund VIII, and Affiliates Fund VIII entered into Share Subscription Agreements to acquire Series C preferred shares. |
| December 20, 2022 | Amended and Restated Shareholder's Agreement dated; Issuer's F-1 registration statement initially filed. |
| January 16, 2023 | Lock-Up Side Letter and Form of Lock-Up Letter dated. |
| January 23, 2023 | Issuer's F-1 (file No. 333-268907) amended, initially filed. |
| January 24, 2023 | Preferred shares held by DCM funds converted to Ordinary Shares; DCM funds acquired 400,000 ADSs (1,200,000 Ordinary Shares) in the Company's Offering; Amended and Restated Shareholders' Agreement became effective. |
| March 26, 2024 | DCM funds purchased 25,197 ADSs (75,591 Ordinary Shares) in an open market purchase for $104,305.50. |
| March 27, 2024 | DCM funds purchased 18,370 ADSs (54,810 Ordinary Shares) in an open market purchase for $75,891.75. |
| March 28, 2024 | DCM funds purchased 46,357 ADSs (139,071 Ordinary Shares) in an open market purchase for $189,943.17. |
| June 30, 2024 | Date of outstanding Ordinary Shares (103,776,127) used for percentage ownership calculation. |
| August 29, 2024 | Date QuantaSing Group Ltd. filed its Form 20-F reporting outstanding shares. |
| November 17, 2023 | Original Schedule 13D filing date. |
| February 14, 2025 | Signature date of this Amendment No. 1 to Schedule 13D. |
Keywords
QuantaSing Group, QSG, DCM Ventures, Schedule 13D, beneficial ownership, share repurchase, open market purchase, Class A Ordinary Shares, American Depositary Shares, ADSs, institutional investment, venture capital
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.